{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-017172","form_type":"8-K","ticker":"STAA","cik":"0000718937","company_name":"STAAR SURGICAL CO","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.045405+00:00","generated_at":"2026-06-16T01:54:55.224647+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"STAAR Surgical Q1 net sales up 16% to $73.5M; raises FY2023 outlook to $348M","bullets":["ICL sales of $70.6M up 20% YoY; ICL units also up 20%.","GAAP EPS $0.05 vs $0.19; adjusted EPS $0.18 vs $0.29.","Fiscal 2023 net sales outlook raised to $348M from $340M, implying 28% ICL growth.","Gross margin improved to 78.3% from 77.9%.","Cash & investments at $217.3M, down from $225.5M at Q4 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-017172","json":"https://secwatch.observer/filing/0000950170-23-017172.json","markdown":"https://secwatch.observer/filing/0000950170-23-017172.md","text":"https://secwatch.observer/filing/0000950170-23-017172.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/718937/000095017023017172/0000950170-23-017172-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/718937/000095017023017172/staa-20230503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T01:54:55.224647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"afc31751cd610b1473bae4c468df57f862cb7ed2","claim":"STAAR SURGICAL CO reported first quarter ended March 31, 2023 results: revenue $73.5 million, net income $2.7 million or $0.05 per diluted share, EPS $0.05 per diluted share. Guidance raised.","evidence_excerpt":"in the filing unless specifically stated so therein . --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 STAAR Surgical Reports First Quarter 2023 Results Q1 2023 Net Sales of $73.5 Million; ICL Sales of $70.6 Million Up 20% Y/Y Fiscal 2023 Net Sales Outlook Raised to $348 Million; ICL Sales to $345 Million Up 28% Y/Y LAKE FOREST, CA, May 3, 2023 --- STAAR Surgical","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/718937/000095017023017172/0000950170-23-017172-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$73.5 million"},{"label":"Net income","value":"$2.7 million or $0.05 per diluted share"},{"label":"EPS","value":"$0.05 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}